Blue Cross Blue Shield of Massachusetts was among the series B-1 investors, adding to the $17m of series B cash secured by InfoBionic in April 2014.

US-based healthcare IT company InfoBionic secured $8m in series B-1 financing yesterday from investors including Zaffre Investments, an investment vehicle belonging to insurance provider Blue Cross Blue Shield of Massachusetts.

Growth capital firm Safeguard Scientifics led the round, which featured contributions from Excel Venture Management and a range of undisclosed angel investors.

Safeguard previously led the initial $17m series B round raised by InfoBionic in April 2014 from backers also including Mass Medical Angels, Broadview Ventures, Tie Angels, Beta Fund,…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?